Section 232 Is the Pharma Tariff. Drug-Pricing Section 301 Is the Record-Building Track.
Not yet a Section 301 tariff. USTR has opened the drug-pricing record, but the live duty exposure remains Proclamation 11020's Section 232 regime.
Written byTRAVERSE Research
Primary lensTariff authority
Evidence base11 records used
Use caseAuthority exposure review
Current analysis
Continue with Paid.
Paid opens current, deep, and evergreen analysis plus full tool output, proactive alerts, and saved-scope monitoring.